[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE117989T1 - Prostaglandinanaloge enthaltende lipidemulsion. - Google Patents

Prostaglandinanaloge enthaltende lipidemulsion.

Info

Publication number
ATE117989T1
ATE117989T1 AT90119772T AT90119772T ATE117989T1 AT E117989 T1 ATE117989 T1 AT E117989T1 AT 90119772 T AT90119772 T AT 90119772T AT 90119772 T AT90119772 T AT 90119772T AT E117989 T1 ATE117989 T1 AT E117989T1
Authority
AT
Austria
Prior art keywords
lipide
emulsion containing
prostaglandin analogue
containing prostaglandin
analogue
Prior art date
Application number
AT90119772T
Other languages
English (en)
Inventor
Yutaka Mizushima
Toshihide Seikagaku Ko Inomata
Nihonbashi-Honcho
Arata Yasuda
Original Assignee
Yutaka Mizushima
Asahi Glass Co Ltd
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yutaka Mizushima, Asahi Glass Co Ltd, Seikagaku Kogyo Co Ltd filed Critical Yutaka Mizushima
Application granted granted Critical
Publication of ATE117989T1 publication Critical patent/ATE117989T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
AT90119772T 1989-10-16 1990-10-15 Prostaglandinanaloge enthaltende lipidemulsion. ATE117989T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1266230A JP2602964B2 (ja) 1989-10-16 1989-10-16 プロスタグランジン類縁体およびその脂肪乳剤

Publications (1)

Publication Number Publication Date
ATE117989T1 true ATE117989T1 (de) 1995-02-15

Family

ID=17428079

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90119772T ATE117989T1 (de) 1989-10-16 1990-10-15 Prostaglandinanaloge enthaltende lipidemulsion.
AT94111337T ATE179169T1 (de) 1989-10-16 1990-10-15 Prostaglandinanaloge

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94111337T ATE179169T1 (de) 1989-10-16 1990-10-15 Prostaglandinanaloge

Country Status (10)

Country Link
US (1) US5120870A (de)
EP (2) EP0423697B1 (de)
JP (1) JP2602964B2 (de)
AT (2) ATE117989T1 (de)
AU (1) AU641436B2 (de)
CA (1) CA2027351C (de)
DE (2) DE69016567T2 (de)
DK (2) DK0423697T3 (de)
ES (2) ES2070238T3 (de)
GR (2) GR3015963T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995019340A1 (fr) * 1994-01-18 1995-07-20 Teijin Limited 7-thiaprostaglandines et procede de production de ces composes
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
ES2315013T3 (es) * 1998-06-04 2009-03-16 Asahi Glass Co., Ltd. Proceso para producir un derivado de prostaglandina purificado.
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
WO2003026611A2 (en) 2001-09-26 2003-04-03 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
WO2005077337A2 (en) * 2004-02-05 2005-08-25 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
EP1655021B1 (de) 2004-11-09 2008-10-29 Novagali Pharma SA Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
WO2007042262A2 (en) * 2005-10-10 2007-04-19 Novagali Pharma Sa Ophthalmic emulsions containing prostaglandins
EP1809237B1 (de) * 2004-11-09 2008-12-31 Novagali Pharma SA Ophthalmische öl-in-wasser-emulsion mit stabilem positivem zeta-potential
US8334321B2 (en) 2006-09-05 2012-12-18 Q.P. Corporation Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
EP2228058A1 (de) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionische Öl-in-Wasser-Emulsion mit Prostaglandinen und Verwendungen dafür
EP2389939A1 (de) 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
SG187770A1 (en) 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363817A (en) * 1981-08-27 1982-12-14 Miles Laboratories, Inc. Enol acylate analogs of E1 and E2 prostaglandins
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPS61151126A (ja) * 1984-12-25 1986-07-09 Teijin Ltd △７―プロスタグランジンａ１類を有効成分として含有する注射用の脂肪乳剤

Also Published As

Publication number Publication date
EP0423697A2 (de) 1991-04-24
CA2027351A1 (en) 1991-04-17
DE69033069T2 (de) 1999-08-19
EP0624574A2 (de) 1994-11-17
ES2132279T3 (es) 1999-08-16
AU6452690A (en) 1991-04-18
DK0423697T3 (da) 1995-05-29
JPH03204853A (ja) 1991-09-06
DE69016567D1 (de) 1995-03-16
GR3030718T3 (en) 1999-11-30
CA2027351C (en) 2001-06-19
ATE179169T1 (de) 1999-05-15
ES2070238T3 (es) 1995-06-01
GR3015963T3 (en) 1995-07-31
DE69033069D1 (de) 1999-05-27
EP0624574B1 (de) 1999-04-21
DE69016567T2 (de) 1995-09-21
AU641436B2 (en) 1993-09-23
EP0624574A3 (de) 1995-01-18
EP0423697A3 (en) 1992-08-05
EP0423697B1 (de) 1995-02-01
JP2602964B2 (ja) 1997-04-23
DK0624574T3 (da) 1999-10-25
US5120870A (en) 1992-06-09

Similar Documents

Publication Publication Date Title
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
FI914905A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
PT88603A (pt) Immunomodulatory azapiranes
FI95469C (fi) Analogiamenetelmä uusien hypoglykeemisten oksatsolidiinidionien valmistamiseksi
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
PL286043A1 (en) Method for manufacturing new proteins
ZA883444B (de)
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ES2053707T3 (es) Procedimiento para la preparacion de amidas de acidos 3,3-diaril-acrilicos.
DE3470312D1 (de) Ether of n-propanolamine derivative
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
PT92668A (pt) Processo para a preparacao de derivados de azabiciclo-heptano
NO822809L (no) Fremgangsmaate ved fremstilling av fluorerte diaminohepten- og heptynderivater
GR3006806T3 (de)
AU5977980A (en) Aminodeoxyclavulanic acids
ATE144257T1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee